DianeTsengMD

PubMed

• 7 citations
  New Immuno-oncology Targets and Resistance Mechanisms.
  Molly C Tokaz, Christina S Baik, A McGarry Houghton, Diane Tseng> ;Current Treatment Options in Oncology. 2022 Sep 1
• 2 citations
  Searching for Synergy: Chemotherapy and Checkpoint Inhibitors.
  Diane Tseng, Justin F Gainor> ;Clinical Cancer Research. 2022 Jun 1
• 4 citations
  Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer.
  Diane Tseng, Sukhmani K. Padda, Heather A. Wakelee> ;Journal of Thoracic Oncology. 2018 Jun 1
• 63 citations
  Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
  Shin Heng Chiou, Diane Tseng, Alexandre Reuben, Vamsee Mallajosyula, Irene S. Molina, Stephanie D. Conley, Julie Wilhelmy, Alana McSween, Xinbo Yang, Daisuke Nishimiya...> ;Immunity. 2021 Mar 9
• 456 citations
  Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.
  Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham, Humberto Contreras-Trujillo, John W. Fathman, Nathaniel B. Fernhoff, Jun Seita, Matthew A. Inlay, Kipp Weiskopf...> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Jul 2
• 181 citations
  Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
  Jin, M., Barzin Y. Nabet, Mohammad Shahrokh Esfahani, Everett J. Moding, Emily G. Hamilton, Jacob J. Chabon, Hira Rizvi, Chloé B. Steen, Aadel A. Chaudhuri, Chih Long ...> ;Cell. 2020 Oct 15
• 181 citations
  Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer
  Justin F. Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo-Jack, Luc Friboulet, Jessica J. Lin, Harper Hubbeling, Leila Dardaei, Anna F. Farago, Katherine Schultz, Lor...> ;JCO Precision Oncology. 2017 Aug 16
• 2 citations
  Cardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib Therapy.
  Diane Tseng, Xenos Mason, Tomas G. Neilan, Ryan J. Sullivan> ;The Oncologist. 2016 Sep 1
• 23 citations
  Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy.
  Frank W. Chen, Diane Tseng, Sunil Reddy, Adil Daud, Susan M. Swetter> ;JAMA Dermatology. 2014 Nov 1
• 26 citations
  Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract
  Diane Tseng, Julie Kim, Andrea Warrick, Dylan Nelson, Marina Pukay, Carol Beadling, Michael Heinrich, Maria Angelica Selim, Christopher L. Corless, Kelly C. Nelson> ;Journal of the American Academy of Dermatology. 2014 Aug 1
• 67 citations
  Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
  M. J. Walters, Karen Ebsworth, Robert D. Berahovich, M. E T Penfold, Shie-Chau Liu, R. Al Omran, M. Kioi, Sophia B. Chernikova, Diane Tseng, Erin E. Mulkearns-Hubert, ...> ;British Journal of Cancer. 2014 Mar 4
• 1075 citations
  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
  Stephen B. Willingham, Jens Peter Volkmer, Andrew J. Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Ju...> ;Proceedings of the National Academy of Sciences of the United States of America. 2012 Apr 24
• 33 citations
  Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
  Diane Tseng, Leelanand P. Rachakonda, Zheng Su, Ranjana H. Advani, Sandra J. Horning, Richard T. Hoppe, Andrew Quon, Edward E. Graves, Billy W. Loo, Phuoc T. Tran> ;Radiation Oncology. 2012 Jan 19
• 69 citations
  Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
  Diane Tseng, D A Vasquez-Medrano, J M Brown> ;British Journal of Cancer. 2011 Jun 7
• 1 citations
  Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL.
  Diane Tseng, Carol D. Jones, Matthew W. Anderson, Roger A. Warnke, James L. Zehnder, David B. Miklos> ;Bone Marrow Transplantation. 2011 Jan 24
• 5 citations
  Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
  Pavan Bachireddy, Diane Tseng, Melissa Horoschak, Daniel T. Chang, Albert C. Koong, Daniel S. Kapp, Phuoc T. Tran> ;Radiation Oncology. 2010 Nov 8
• 277 citations
  Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
  G-One Ahn, Diane Tseng, Cho-Hwa Liao, Mary Jo Dorie, Agnieszka Czechowicz, J. Martin Brown> ;Proceedings of the National Academy of Sciences of the United States of America. 2010 May 4
• 142 citations
  Cancer stem cell-directed therapies: recent data from the laboratory and clinic.
  Christopher Y. Park, Diane Tseng, Irving L. Weissman> ;Molecular Therapy. 2009 Feb 1
• 89 citations
  Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease
  Suparna Dutt, Diane Tseng, Joerg Ermann, Tracy I. George, Yin Ping Liu, Corrine R. Davis, C. Garrison Fathman, Samuel Strober> ;Journal of Immunology. 2007 Nov 15
• 60 citations
  L-selectin and β7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease
  Suparna Dutt, Joerg Ermann, Diane Tseng, Yin Ping Liu, Tracy I. George, C. Garrison Fathman, Samuel Strober> ;Blood. 2005 Dec 1
• Join now to see all